SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
288J Neurosci. 2006 May 24;26(21):5794-9. Cannabinoid receptor type 1 located on scaram(o)uche-6/11/2006
287Neuropharmacology. 2006 Jun 1; [Epub ahead of print] Antiobesity effects of thscaram(o)uche-6/7/2006
286thanks. I'll stick to vegetables.freelyhovering-5/27/2006
285thanks.freelyhovering-5/27/2006
284My personal belief is that "grass equivalents" would contain THC and ascaram(o)uche-5/26/2006
283Does his mean that grass equivalents both help and harm, or just help in liver ffreelyhovering-5/26/2006
282Nat Med. 2006 May 21; [Epub ahead of print] CB1 cannabinoid receptor antagonisscaram(o)uche-5/25/2006
281"R-SAT" assay technology overviewed here. Apparently it's an impotuck-5/24/2006
280ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering Thursday Aprilmopgcw-4/29/2006
279ACADIA Pharmaceuticals Announces Proposed Public Stock Offering Monday April 24,sim1-4/24/2006
278<i>CB1 antagonists are not sumthin I'm gonna sprinkle on MY cheerios.&DewDiligence_on_SI-4/20/2006
277I read somewhere fda may be asking for 3 year safety data on fty720 in MS, whichkeokalani'nui-4/19/2006
276agreed, i reviewed the info, and it is pre-clinical they have an option on. thamopgcw-4/19/2006
275try to make up for my flub at t/fif..... <i>1.2 “ACADIA Know-How” shall mscaram(o)uche-4/19/2006
274CB1 antagonists are not sumthin I'm gonna sprinkle on MY cheerios. Might bescaram(o)uche-4/19/2006
273Since you're winking, I assume that you know what my point is..... that tscaram(o)uche-4/19/2006
272Thanks Wilder. That settles it. Pre-clinical, it is not.LJM-4/19/2006
271My notes say: Sepracor has an option for exclusive worldwide rights to develop keokalani'nui-4/19/2006
270Many thanks for the intrusion. I really am wondering why no mention in the newsLJM-4/19/2006
269pardon my intrusion, and i may be wrong, but sepracor has dibs on a ht52xxx compmopgcw-4/19/2006
268Nigel, Is ACAD partnered with Sepracor on this? I thought they were partneringLJM-4/19/2006
267ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating Tnigel bates-4/19/2006
266Clinical Data Achieves Validation of Genetic Biomarker for Determining Risk of Cnigel bates-4/19/2006
265Related article... Editorial Practical Treatment Information for Schizophrenia sim1-4/16/2006
264Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Pattnsaf-4/16/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News